Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity? [electronic resource]
Producer: 20190813Description: 659-663 p. digitalISSN:- 1555-8576
- Aged
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers
- Colorectal Neoplasms -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Immunohistochemistry
- Liver Neoplasms -- diagnosis
- Molecular Targeted Therapy
- Mutation
- Proto-Oncogene Proteins p21(ras) -- genetics
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.